Value of Apoptotic, Antiapoptotic, and Cell Proliferation Markers in the Treatment of Graves’ Disease

Table 5

Expression of antiapoptotic markers in thyrocytes and lymphocytes in patients with GD according to the type of treatment (chi-square test/Fisher’s exact test).

Markers	Cells		ATD (%)	Without ATD (%)	RIT (%)	Beta-blocker (%)
BCL-2	Thyrocytes	<30%	6.82	25	16.67	13.51
		>30%	93.18	75	83.33	86.49
		value	0.1643		0.4952	0.3049
	Lymphocytes	<30%	84.09	87.5	100	91.89
		>30%	15.91	12.5	0	8.11
		value	1.0		0.5742	0.0358
MCL-1	Thyrocytes	<20%	4.55	25	16.67	8.11
		>20%	95.45	75	83.33	91.89
		value	0.1072		0.4175	1.0
	Lymphocytes	<20%	75	37.5	100	81.08
		>20%	25	62.5	0	18.92
		value	0.0889		0.1588	0.0069